A Long-Acting Formulation of the Integrase Inhibitor Raltegravir Protects Humanized BLT Mice From Repeated High-Dose Vaginal HIV Challenges

Journal of Antimicrobial Chemotherapy - United Kingdom
doi 10.1093/jac/dkw042

Related search